The identification of clinically relevant genetic mutations in renal cell carcinoma is an important step on the path toward personalized management of this disease.
European urology focus. 2016 Jul 30 [Epub ahead of print]
Shreyas Joshi, Alexander Kutikov
Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA. , Division of Urologic Oncology, Department of Surgical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, PA, USA. Electronic address: .